U.S. Physical Therapy Inc. (USPH) Business Metric Overview - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    U.S. Physical Therapy Inc...

    NYSE: USPH · Real-Time Price · USD
    83.38
    0.86 (1.04%)
    At close: Sep 26, 2025, 3:59 PM
    82.00
    -1.66%
    After-hours: Sep 26, 2025, 06:26 PM EDT

    U.S. Physical Therapy Revenue Breakdown

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
    Net Patient Revenues Revenue 164.18M 152.55M 150.06M 139.15M 140.27M 131.07M 258.69M 127.24M 129.28M 126.58M 120.15M 116.71M 118.2M 109.54M 113.51M 112.33M 113.24M 99.25M 104.54M 96.4M 72.28M 100.13M 108.94M 104.39M 113.36M 106.65M 107.81M 103.35M 105.99M 100.55M
    Net Patient Revenues Revenue Growth +7.63% +1.66% +7.84% -0.80% +7.02% -49.33% +103.31% -1.58% +2.13% +5.36% +2.94% -1.26% +7.90% -3.50% +1.05% -0.80% +14.09% -5.05% +8.44% +33.37% -27.81% -8.09% +4.36% -7.91% +6.29% -1.07% +4.31% -2.49% +5.41% n/a
    Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues Revenue 33.16M 31.24M 30.39M 28.89M 26.92M 24.6M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues Revenue Growth +6.15% +2.81% +5.19% +7.31% +9.43% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Operating Expense Breakdown

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
    Selling, General, and Administrative Revenue n/a 16.25M 15.57M 14.38M 11.45M 15.71M 11.36M 9.61M 12.14M 13.86M 11.93M 11.89M 10.74M 11.56M 10.72M 12.87M 12.07M 10.87M 10.92M 10.42M 9.02M 11.68M 11.67M 10.56M 11.53M 11.29M 10.41M 10.64M 10.13M 10.16M 10.18M 8.3M 8.86M 8.55M 7.84M 7.61M 8.03M 9M 8.89M 6.92M 7.59M 7.66M
    Selling, General, and Administrative Revenue Growth -100.00% +4.33% +8.24% +25.61% -27.11% +38.31% +18.26% -20.91% -12.37% +16.22% +0.30% +10.69% -7.05% +7.82% -16.70% +6.57% +11.04% -0.38% +4.74% +15.52% -22.74% +0.03% +10.58% -8.42% +2.07% +8.43% -2.14% +5.08% -0.34% -0.19% +22.62% -6.23% +3.62% +9.03% +3.01% -5.18% -10.86% +1.24% +28.47% -8.82% -0.84% n/a
    Research and Development Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Add to Watchlist